These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26714598)

  • 1. [Associations between interleukin-17A expression and epithelial-mesenchymal transition in patients with hepatocellular carcinoma].
    Xu J; Wang J; Hu Y; Cheng L; Yu H
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):585-90. PubMed ID: 26714598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of sal-like 4 in primary hepatocellular carcinoma and its association with epithelial-mesenchymal transition].
    Xu J; Wang J; Hu Y; Wang XX; Cheng LL; Yu HY
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):500-505. PubMed ID: 27784427
    [No Abstract]   [Full Text] [Related]  

  • 3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
    Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma.
    Xu QG; Yu J; Guo XG; Hou GJ; Yuan SX; Yang Y; Yang Y; Liu H; Pan ZY; Yang F; Gu FM; Zhou WP
    Mol Oncol; 2018 Jun; 12(6):936-952. PubMed ID: 29689643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
    Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy.
    Mima K; Hayashi H; Imai K; Kuroki H; Nakagawa S; Okabe H; Chikamoto A; Watanabe M; Beppu T; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Apr; 20(4):429-34. PubMed ID: 23238743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells.
    Ye T; Xu J; Du L; Mo W; Liang Y; Xia J
    Cell Physiol Biochem; 2017; 41(4):1584-1595. PubMed ID: 28334716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
    Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma.
    Xiao S; Liu L; Fang M; Zhou X; Peng X; Long J; Lu X
    Dig Dis Sci; 2015 Apr; 60(4):910-8. PubMed ID: 25362514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma.
    Yamanaka C; Wada H; Eguchi H; Hatano H; Gotoh K; Noda T; Yamada D; Asaoka T; Kawamoto K; Nagano H; Doki Y; Mori M
    Jpn J Clin Oncol; 2018 Jan; 48(1):52-60. PubMed ID: 29145632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma.
    Liu Y; Jiang P; Wang G; Liu X; Luo S
    Eur J Surg Oncol; 2018 Jul; 44(7):1087-1093. PubMed ID: 29764705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
    Hou KZ; Fu ZQ; Gong H
    World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.
    Zhai X; Zhu H; Wang W; Zhang S; Zhang Y; Mao G
    Med Oncol; 2014 Jun; 31(6):970. PubMed ID: 24781336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
    Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
    Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT.
    Zheng X; Gai X; Wu Z; Liu Q; Yao Y
    Oncol Rep; 2013 May; 29(5):1811-8. PubMed ID: 23483190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
    Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
    PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
    Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
    Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.